Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 4293429 | https://doi.org/10.1155/2017/4293429

Chian-Jiun Liou, Xuan-Yu Lai, Ya-Ling Chen, Chia-Ling Wang, Ciao-Han Wei, Wen-Chung Huang, "Corrigendum to “Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway”", Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 4293429, 1 page, 2017. https://doi.org/10.1155/2017/4293429

Corrigendum to “Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway”

Received30 Oct 2017
Accepted16 Nov 2017
Published03 Dec 2017

In the article titled “Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway” [1] the statement “Ginkgolide C, isolated from Ginkgo biloba leaves, is a flavone reported to have multiple biological functions, from decreased platelet aggregation to ameliorating Alzheimer disease” in the Abstract section should be changed to “Ginkgolide C, isolated from Ginkgo biloba leaves, is a diterpene lactone derivative reported to have multiple biological functions, from decreased platelet aggregation to ameliorating Alzheimer disease.”

References

  1. C.-J. Liou, X.-Y. Lai, Y.-L. Chen, C.-L. Wang, C.-H. Wei, and W.-C. Huang, “Ginkgolide C suppresses adipogenesis in 3T3-L1 adipocytes via the AMPK signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 298635, 10 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2017 Chian-Jiun Liou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views628
Downloads220
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.